Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
January 26, 2026 17:00 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
January 23, 2026 17:25 ET | Source: Immunovant Inc. DURHAM, N.C. and…
STL reports Q3 FY’26 results; strengthens technology leadership
MUMBAI, India, Jan. 23, 2026 /PRNewswire/ -- STL (NSE: STLTECH), a leading…
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 22, 2026 16:05 ET | Source: Adaptive Biotechnologies SEATTLE, Jan. 22,…
Canara HSBC Life Insurance Delivers Robust 9M FY26 Results
PERFORMANCE FOR THE QUARTER ENDED DECEMBER 31, 2025Individual weighted premium income of…
Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System
Results demonstrate a favorable safety profile and functional improvements in patients with…
Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ --…
Nxera Pharma Reports Positive Results From Phase 3 Trial of Daridorexant in South Korea
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for…
Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Company to host conference call and webcast on Tuesday, January 20, 2026…
Bank of America Reports Fourth Quarter 2025 Financial Results
CHARLOTTE, N.C., Jan. 14, 2026 /PRNewswire/ -- Bank of America reported its…
